HDM201 and Pazopanib in Patients With P53 Wild-type Advanced/Metastatic Soft Tissue Sarcomas
HDM201 and Pazopanib in Patients With P53 Wild-type Advanced/Metastatic Soft Tissue Sarcomas
Active, not recruiting · NCT05180695 · Registry updated 2026-06-22Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| HDM201 and Pazopanib in Patients With P53 Wild-type Advanced/Metastatic Soft Tissue Sarcomas | Neoplasms by Histologic Type, Neoplasms, Connective and Soft Tissue, neoplasm, sarcoma | Active, not recruiting | Phase 1 / Phase 2 | 2026-06-22 | NCT05180695 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Centre Leon Berard | 67 |
| National Cancer Institute, France | 61 |
| Novartis | 114 |
5 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Centre Léon Bérard | Lyon | France | 77 |
| Institut Bergonié | Bordeaux | France | 1 |
| Institut Claudius Regaud | Toulouse | France | 40 |
| Institut Gustave Roussy | Villejuif | France | 113 |
| Institut Paoli-Calmettes | Marseille | France | 19 |